Investors

CAPITAL STRUCTURE AND QUOTE
FINANCIAL STATEMENTS
AGM

Capital Structure

Shares Outstanding

21,234,278

Warrants

54,498,998

45,999,000 @ $1.20(1)(2)

July 15, 2024

7,499,998 @ $0.15

March 15, 2026

1,000,000 @ $0.50

August 29, 2027

Options

615,400

150,000 @ $1.05

July 17, 2024

65,000 @ $1.15

September 1, 2024

100,000 @ $1.30

January 1, 2026

200,000 @ $0.55

November 18, 2026

54,000 @ $3.00

March 7, 2027

15,000 @ $3.60

May 29, 2027

25,000 @ $5.50

May 29, 2027

6,400 @ $3.90

April 20, 2028

Fully Diluted

34,949,576

As of November 3, 2023
(1) Trading as MEX.wt
(2) Conversion terms: Every ten (10) warrants convertible into one (1) share at an exercise price of $1.20 per share

Capital Structure

Stock Exchange

TSX Venture

Transfer Agent

Computershare

Auditors

Grant Thornton LLP

Lawyers

Farris Law LLP

FINANCIAL STATEMENTS

Select Year:

2025

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Financial Statements

Q2 2025 - Financial Statements Q2 2025 - MD&A

Q1 2025 - Financial Statements Q1 2025 - MD&A

Financial Statements

Q4 2024 - Financial Statements Q4 2024 - MD&A

Q3 2024 - Financial Statements Q3 2024 - MD&A

Q2 2024 - Financial Statements Q2 2024 - MD&A

Q1 2024 - Financial Statements Q1 2024 - MD&A

Financial Statements

Q4 2023 - Financial Statements Q4 2023 - MD&A

Q3 2023 - Financial Statements Q3 2023 - MD&A

Q2 2023 - Financial Statements Q2 2023 - MD&A

Q1 2023 - Financial Statements Q1 2023 - MD&A

Financial Statements

Q4 2022 - Financial Statements Q4 2022 - MD&A

Q3 2022 - Financial Statements Q3 2022 - MD&A

Q2 2022 - Financial Statements Q2 2022 - MD&A

Q1 2022 - Financial Statements Q1 2022 - MD&A

Financial Statements

Q4 2021 - Financial Statements Q4 2021 - MD&A

Q3 2021 - Financial Statements Q3 2021 - MD&A

Q2 2021 - Financial Statements Q2 2021 - MD&A

Q1 2021 - Financial Statements Q1 2021 - MD&A

Financial Statements

Q4 2020 - Financial Statements Q4 2020 - MD&A

Q3 2020 - Financial Statements Q3 2020 - MD&A

Q2 2020 - Financial Statements Q2 2020 - MD&A

Q1 2020 - Financial Statements Q1 2020 - MD&A

Financial Statements

Q4 2019 - Financial Statements Q4 2019 - MD&A

Q3 2019 - Financial Statements Q3 2019 - MD&A

Q2 2019 - Financial Statements Q2 2019 - MD&A

Q1 2019 - Financial Statements Q1 2019 - MD&A

Financial Statements

Q4 2018 - Financial Statements Q4 2018 - MD&A

Q3 2018 - Financial Statements Q3 2018 - MD&A

Q2 2018 - Financial Statements Q2 2018 - MD&A

Q1 2018 - Financial Statements Q1 2018 - MD&A

Financial Statements

Q4 2017 - Financial Statements Q4 2017 - MD&A

Q3 2017 - Financial Statements Q3 2017 - MD&A

Q2 2017 - Financial Statements Q2 2017 - MD&A

Q1 2017 - Financial Statements Q1 2017 - MD&A

Financial Statements

Year End 2016 - Financial Statements Year End 2016 - Management Discussion & Analysis

Q3 2016 - Financial Statements Q3 2016 - MD&A

AGM

Notice of Meeting Combined Notice of Meeting and Information Circular Form of Proxy Financial Statements Request Form

CAPITAL STRUCTURE AND QUOTE
FINANCIAL STATEMENTS
AGM

Investors

Capital Structure

FINANCIAL STATEMENTS

AGM

Get in touch